Do you want to read an article? Please log in or register.
FDG-PET/CT for pretherapeutic lymph node staging in non-small cell lung cancer: A tailored approach to the ESTS/ESMO guideline workflow
Lung Cancer
RECOMMENDED
Related content
RECOMMENDED
Lung Cancer
Definitive treatment patterns and survival in stage II non-small cell lung cancer
doi: 10.1016/j.lungcan.
RECOMMENDED
Lung Cancer
Pre-surgical assessment of mediastinal lymph node metastases in patients having ≥ 30 mm non-small-cell lung cancers
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lung Cancer
Zhu Y, Cai Q, Wang Y, You N, Yip R, Lee DS, Taioli E, Flores R, Henschke CI, Yankelevitz DF
doi: 10.1016/j.lungcan.2021.09.013
RECOMMENDED
Lung Cancer
Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503).
Lancet Respir Med.
Altorki NK, Wang X, Wigle , Gu L, Darling G, Ashrafi AS, Landrenau R, Miller D, Liberman M, Jones DR, Keenan R, Conti M, Wright G, Veit LJ, Ramalingam SS, Kamel M, Pass HI, Mitchell JD, Stinchcombe T, Vokes E, Kohman L
doi: 10.1016/S2213-2600
RECOMMENDED
Lung Cancer
Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Lancet Oncol.
Nestle U, Schimek-Jasch T, Kremp S, Schaefer-Schuler A, Mix M, Küsters A, Tosch M, Hehr T, Eschmann SM, Bultel YP, Hass P, Fleckenstein J, Thieme A, Stockinger M, Dieckmann K, Miederer M, Holl G, Rischke HC, Gkika E, Adebahr S, König J, Grosu AL, PET-Plan study group
doi: 10.1016/S1470-2045(20)30013-9.
RECOMMENDED
Lung Cancer
Automated chromogenic multiplexed immunohistochemistry assay for diagnosis and predictive biomarker testing in non-small cell lung cancer
Lung Cancer.
Ilie M, Beaulande M, Hamila M, Erb G, Hofman V, Hofman P
doi: 10.1016/j.lungcan.
RECOMMENDED
Lung Cancer
Guideline adherence of mediastinal staging of non-small cell lung cancer: A multicentre retrospective analysis
Lung Cancer.
Bousema JE, van Dorp M, Hoeijmakers F, Huijbregts IA, Barlo NP, Bootsma GP, van Boven WP, Claessens NJM, Dingemans AC, Hanselaar WE, Kortekaas RTJ, Lardenoije JHP, Maessen JG, Schreurs WH, Vissers Y, Youssef-El Soud M, Dijkgraaf MGW, Annema J, van den Broek FJC
doi: 10.1016/
RECOMMENDED
Lung Cancer
Variation between multidisciplinary tumor boards in clinical staging and treatment recommendations for patients with locally advanced non-small cell lung cancer
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Chest.
Hoeijmakers F, Heineman DJ, Daniels JM, Beck N, Tollenaar RAEM, Wouters MWJM, Marang-van de Mheen PJ, Schreurs WH, MDT study group
doi: 10.1016/j.chest.2020.07.054.
RECOMMENDED
Lung Cancer
Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study
★ 1
Recommended by
Prof. Dr Stephan Bodis, Faculty Member
★ 2
Recommended by
Alexander Meisel, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Oncol.
Hui R, Özgüroğlu M, Villegas A, Daniel D, Vicente D, Murakami S, Yokoi T, Chiappori A, Lee KH, de Wit M, Cho BC, Gray JE, Rydén A, Viviers L, Poole L, Zhang Y, Dennis PA, Antonia SJ
doi: 10.1016/S1470-2045(19)30519-4.
RECOMMENDED
Lung Cancer
Prognostic relevance of regional lymph-node distribution in patients with N1-positive non-small cell lung cancer: A retrospective single-center analysis
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Lung Cancer.
Eichhorn F, Klotz LV, Muley T, Kobinger S, Winter H, Eichhorn ME
doi: 10.1016/j.lungcan.2019.10.018.